TY - JOUR
T1 - Hospital and outpatient health services utilization among HIV-infected patients in care in 1999
AU - Crane, Lawrence
AU - Crowe, Robb
AU - Fine, Steven
AU - Gold, Marla
AU - Gorosh, Kathye
AU - Gourevitch, Marc
AU - Hellinger, James
AU - Jovanovich, John
AU - Kalkut, Gary
AU - Keiser, Philip
AU - Matthews, Chris
AU - Nadler, Jeffrey
AU - Nemechek, Patrick
AU - Post, John
AU - Goldberg, Bruce
AU - Rutstein, Richard
AU - Sharp, Victoria
AU - Hellinger, Fred
AU - Fleishman, John
AU - Frazer, Irene
AU - Conviser, Richard
AU - Dilonardo, Joan
AU - Gaist, Paul
AU - Moore, Richard
AU - Keruly, Jeanne
AU - Gebo, Kelly
AU - Reilly, Erin
AU - Zhao, Ming
PY - 2002/5/1
Y1 - 2002/5/1
N2 - Background: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV-infected patients, and health care resource use data are also needed to support policy and financial decision making. Methods: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits. Results: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm3 to 840 per 100 persons/mo for a CD4 < 50 cells/mm3 (p < .01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV-1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168, respectively. Conclusion: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.
AB - Background: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV-infected patients, and health care resource use data are also needed to support policy and financial decision making. Methods: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits. Results: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm3 to 840 per 100 persons/mo for a CD4 < 50 cells/mm3 (p < .01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV-1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168, respectively. Conclusion: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.
KW - Antiretroviral therapy
KW - Cost of care
KW - Health services
KW - Hospital admission
KW - Resource use
UR - http://www.scopus.com/inward/record.url?scp=18344385139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18344385139&partnerID=8YFLogxK
U2 - 10.1097/00126334-200205010-00003
DO - 10.1097/00126334-200205010-00003
M3 - Article
C2 - 12048359
AN - SCOPUS:18344385139
SN - 1525-4135
VL - 30
SP - 21
EP - 26
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 1
ER -